Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof

Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof

US Patent 9452197 · Granted Sep 27, 2016

Estimated economic value: $18,543,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using ALK2 inhibitors2025
Method for producing levulinic acid2025
Methods of treating iron overload with a BMP inhibitor2025
Methods of using activin receptor type IIB variants2025
Cache circuit that selectively stores data blocks to dynamically optimize for re2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
GDNF fusion polypeptides and methods of use thereof2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Methods for treating heterotopic ossification2025